Epic tools can increase racial/ethnic diversity in clinical research
A closer look at how BPA and MyChart have been instrumental in helping connect with a diverse patient population in clinical research.
Read MoreA closer look at how BPA and MyChart have been instrumental in helping connect with a diverse patient population in clinical research.
Read MoreA clinical trial has the potential to improve the prognosis for patients with pancreatic adenocarcinoma.
Read MoreClinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.
Read MoreAbout one of every five breast cancers presents with high levels of HER2 proteins. Known as HER2-positive breast cancer, these tumors typically show an aggressive
Read MoreNeuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In April, during the annual meeting of
Read MoreWhen it comes to cancer, one-size-does-not-fit-all. “One of the challenges that we have when taking care of patients with bladder cancer is that from one
Read MoreDoctors, patients, and researchers are frustrated when a new healthcare approach works well in a study, but then has disappointing results in the “real world.”
Read MoreT cell therapies have demonstrated encouraging results and benefits in patients with lymphoma resistant to chemotherapy, but, despite these advances, a large number of patients
Read MoreThis time of year, there’s always a lot of discussion about the flu – vaccines, outbreaks, comparisons to previous years, and more. It wasn’t too
Read More